Embryotoxicity of fluconazole on developing chick embryos
-
Published:2024-04-15
Issue:1
Volume:85
Page:
-
ISSN:2090-990X
-
Container-title:The Journal of Basic and Applied Zoology
-
language:en
-
Short-container-title:JoBAZ
Author:
Sattar Rao Zahid, Bilal AsifORCID, Bashir Sadia, Iftikhar AnisaORCID, Yaqoob Irfan
Abstract
Abstract
Background
Fluconazole is a first-generation triazole used as an antifungal treatment for skin, hair, and nail infections. The study aimed to assess the embryotoxicity and teratological effects of fluconazole on chick embryos. Fertilized eggs were divided into four groups: two experimental groups treated with different concentrations of fluconazole (0.1 ml/egg, 0.2 ml/egg) containing 12 and 11 eggs, respectively, one group treated with distilled water (10 eggs), and a control group (10 eggs) left untreated. The liquid form of fluconazole was administered on the 4th day of incubation, and observations were made on the 9th day.
Results
There were different anomalies observed in them like hydrocephaly, microcephaly shorting of the beak, agenesis, Amelia, micromelia, anophthalmia, microphthalmia, and kyphosis. There were also observed the morphometric measurements with a difference of significant (p < 0.001) and (p < 0.01) in CR length, body weight, head circumference, eye circumference, forelimb, and hind limb. Different vital organ defects were also observed in histological studies. Fluconazole in various combinations has been found to cause embryotoxicity and teratological consequences in chick embryos.
Conclusion
The current study showed that fluconazole is teratogenic in creating chick undeveloped organisms. The embryotoxic impacts were recorded on structural morphometric and graphic levels.
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Aller, A., Martin-Mazuelos, E., Lozano, F., Gomez-Mateos, J., Steele-Moore, L., Holloway, W., Gutierrez, M., Recio, F., & Espinel-Ingroff, A. (2000). Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicrobial Agents and Chemotherapy, 44(6), 1544–1548. 2. Ally, R., Schürmann, D., Kreisel, W., Carosi, G., Aguirrebengoa, K., Dupont, B., Hodges, M., Troke, P., Romero, A., Group, E. C. S. (2001). A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clinical Infectious Diseases, 33(9), 1447–1454. 3. Alrajhi, A. A., Ibrahim, E. A., De Vol, E. B., Khairat, M., Faris, R. M., & Maguire, J. H. (2002). Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. New England Journal of Medicine, 346(12), 891–895. 4. Bellantuono, C., Tofani, S., Di Sciascio, G., & Santone, G. (2013). Benzodiazepine exposure in pregnancy and risk of major malformations: A critical overview. General Hospital Psychiatry, 35(1), 3–8. 5. Bilal, A. (2021a). Impacts of depression on pregnancy: A review. Occupational Medicine & Health Affairs, 9(2).
|
|